Histone Deacetylase Inhibitors Potentiate Vesicular Stomatitis Virus Oncolysis in Prostate Cancer Cells by Modulating NF- B-Dependent Autophagy

Targeting autophagy to enhance oncolytic virus-based cancer therapy

(2013) Songshu Meng et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Preclinical safety and activity of recombinant VSV-IFN-β in an immunocompetent model of squamous cell carcinoma of the head and neck

(2013) Vittal V. S. Kurisetty et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Cytosolic Sensing of Viruses

(2013) Delphine Goubau et al.   IMMUNITY

BCL-2 Inhibitors Sensitize Therapy-resistant Chronic Lymphocytic Leukemia Cells to VSV Oncolysis

(2013) Sara Samuel et al.   MOLECULAR THERAPY

Autophagy in Human Health and Disease

(2013) Augustine M.K. Choi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effectiveness of the Histone Deacetylase Inhibitor (S)-2 against LNCaP and PC3 Human Prostate Cancer Cells

(2013) Anna Laurenzana et al.   PLoS One

Oncolytic virus therapy for cancer: the first wave of translational clinical trials

(2013) Manish R. Patel et al.   Translational Research

Direct molecular interactions between Beclin 1 and the canonical NFκB activation pathway

(2012) Mireia Niso-Santano et al.   Autophagy

A novel image-based cytometry method for autophagy detection in living cells

(2012) Leo Li-Ying Chan et al.   Autophagy

Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β

(2012) S Naik et al.   CANCER GENE THERAPY

Linear Ubiquitination of NEMO Negatively Regulates the Interferon Antiviral Response through Disruption of the MAVS-TRAF3 Complex

(2012) S. Mehdi Belgnaoui et al.   Cell Host & Microbe

Autophagy in antiviral innate immunity

(2012) Clémence Richetta et al.   CELLULAR MICROBIOLOGY

Molecular Mechanism of SAHA on Regulation of Autophagic Cell Death in Tamoxifen-Resistant MCF-7 Breast Cancer Cells

(2012) Young Ju Lee et al.   International Journal of Medical Sciences

Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer

(2012) E. Hastie et al.   JOURNAL OF GENERAL VIROLOGY

The Histone Deacetylase Inhibitor Valproic Acid Lessens NK Cell Action against Oncolytic Virus-Infected Glioblastoma Cells by Inhibition of STAT5/T-BET Signaling and Generation of Gamma Interferon

(2012) Christopher A. Alvarez-Breckenridge et al.   JOURNAL OF VIROLOGY

BAY 11-7082 Is a Broad-Spectrum Inhibitor with Anti-Inflammatory Activity against Multiple Targets

(2012) Jaehwi Lee et al.   MEDIATORS OF INFLAMMATION

HDAC inhibitor-based therapies: Can we interpret the code?

(2012) Maria New et al.   Molecular Oncology

Oncolytic virotherapy

(2012) Stephen J Russell et al.   NATURE BIOTECHNOLOGY

Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death

(2012) N. Gammoh et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A comprehensive glossary of autophagy-related molecules and processes (2ndedition)

(2011) Daniel J Klionsky et al.   Autophagy

p65-Dependent production of interleukin-1β by osteolytic prostate cancer cells causes an induction of chemokine expression in osteoblasts

(2011) Jochen Schulze et al.   CANCER LETTERS

HDACi: molecular mechanisms and therapeutic implications in the innate immune system

(2011) Bandar Ali Suliman et al.   IMMUNOLOGY AND CELL BIOLOGY

A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL

(2011) Jung Jin Hwang et al.   INVESTIGATIONAL NEW DRUGS

Oncolytic Vesicular Stomatitis Virus Induces Apoptosis in U87 Glioblastoma Cells by a Type II Death Receptor Mechanism and Induces Cell Death and Tumor Clearance In Vivo

(2011) Z. D. Cary et al.   JOURNAL OF VIROLOGY

Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans

(2011) Caroline J. Breitbach et al.   NATURE

Viruses and the autophagy machinery

(2010) Marlène Dreux et al.   CELL CYCLE

Oncolytic viruses and histone deacetylase inhibitors—A multi-pronged strategy to target tumor cells

(2010) Thi Lien-Anh Nguyen et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Knockdown of autophagy enhances the innate immune response in hepatitis C virus-infected hepatocytes

(2010) Shubham Shrivastava et al.   HEPATOLOGY

Oncolytic Viruses Move Forward in Clinical Trials

(2010) K. Rowan   JNCI-Journal of the National Cancer Institute

Enhancement of Vaccinia Virus Based Oncolysis with Histone Deacetylase Inhibitors

(2010) Heather MacTavish et al.   PLoS One

Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance

(2010) Andrew Burgess et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

GeneCards Version 3: the human gene integrator

(2010) M. Safran et al.   Database-The Journal of Biological Databases and Curation

Vesicular Stomatitis Virus Induces Apoptosis Primarily through Bak Rather than Bax by Inactivating Mcl-1 and Bcl-XL

(2009) A. F. Pearce et al.   JOURNAL OF VIROLOGY

Viruses and autophagy

(2009) Sagar B. Kudchodkar et al.   REVIEWS IN MEDICAL VIROLOGY

Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers

(2008) Joseph G. Sinkovics et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells

(2008) T Katsura et al.   CANCER GENE THERAPY

A Multiple-Loop, Double-Cube Microarray Design Applied to Prostate Cancer Cell Lines with Variable Sensitivity to Histone Deacetylase Inhibitors

(2008) M. S.Q. Kortenhorst et al.   CLINICAL CANCER RESEARCH

Delta-24-RGD in Combination With RAD001 Induces Enhanced Anti-glioma Effect via Autophagic Cell Death

(2008) Marta M Alonso et al.   MOLECULAR THERAPY

Functional relevance of novel p300-mediated lysine 314 and 315 acetylation of RelA/p65

(2008) Christine Buerki et al.   NUCLEIC ACIDS RESEARCH

Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis

(2008) T. L.-A. Nguyen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA